Qi Yue, Duan An Li, You Qi Sheng, Jonas Jost B, Wang Ningli
*Beijing Tongren Eye Center, Beijing Ophthalmology and Visual Science Key Lab, Beijing Tongren Hospital, Capital Medical University, Beijing, China; †Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Ophthalmology and Visual Science Key Lab, Beijing Tongren Hospital, Capital Medical University, Beijing, China; and ‡Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls, University of Heidelberg, Mannheim, Germany.
Retina. 2015 Feb;35(2):351-7. doi: 10.1097/IAE.0000000000000313.
To evaluate the effect of surgical posterior scleral reinforcement in extremely myopic patients (axial length ≥30 mm) with myopic foveoschisis.
The retrospective interventional case series study included patients with an axial length ≥30 mm, posterior scleral staphyloma, and myopic foveoschisis, who were treated either by posterior scleral reinforcement and 23-gauge 3-port pars plana vitrectomy (posterior scleral reinforcement group) or by vitrectomy (vitrectomy group) alone. All eyes additionally underwent cataract surgery.
The study included 28 patients (28 eyes) with no significant (all P > 0.05) difference between the posterior scleral reinforcement group (n = 14) and the vitrectomy group (n = 14) in age, refractive error, axial length, and preoperative best-corrected visual acuity (BCVA). In addition to posterior scleral staphyloma and foveoschisis, a macular hole, a macular hole-associated retinal detachment, and a macular detachment without macular hole were present in three eyes, five eyes, and one eye, respectively in the study group and in three eyes, three eyes, and six eyes, respectively in the control group. In the study group, BCVA was significantly better after surgery than at baseline (P = 0.005) with an improvement in BCVA in 13 eyes, whereas BCVA was unchanged in 1 eye. In the control group, BCVA at baseline and at the end of follow-up did not differ significantly (P = 0.22). Gain in BCVA was marginally significantly higher in the study group than that in the control group (improvement by 0.69 ± 0.76 logMAR vs. 0.19 ± 0.54 logMAR; P = 0.05). The number of eyes with any improvement in BCVA (13 [93%] eyes vs. 11 [79%] eyes; P = 0.289) did not differ between both groups; an improvement in BCVA by more than 2 lines (10 [71%] eyes vs. 3 [21%] eyes; P = 0.009) was significantly higher in the study group than that in the control group. Anatomical success (defined as closure of macular holes and collapse of the foveoschisis) was achieved earlier in the study group (3.7 ± 3.2 months vs. 6.2 ± 3.0 months; P = 0.04).
Posterior scleral reinforcement in association with vitrectomy, as compared with vitrectomy alone, was associated with a higher improvement in visual acuity in extremely myopic eyes with foveoschisis.
评估手术性后巩膜加固术对患有近视性黄斑劈裂的极高度近视患者(眼轴长度≥30mm)的疗效。
这项回顾性干预性病例系列研究纳入了眼轴长度≥30mm、存在后巩膜葡萄肿和近视性黄斑劈裂的患者,这些患者接受了后巩膜加固术联合23G三通道玻璃体切除术(后巩膜加固术组)或仅接受玻璃体切除术(玻璃体切除术组)。所有患眼均额外接受了白内障手术。
该研究纳入了28例患者(28只眼),后巩膜加固术组(n = 14)和玻璃体切除术组(n = 14)在年龄、屈光不正、眼轴长度和术前最佳矫正视力(BCVA)方面无显著差异(所有P>0.05)。除后巩膜葡萄肿和黄斑劈裂外,研究组分别有3只眼、5只眼和1只眼存在黄斑裂孔、黄斑裂孔相关的视网膜脱离以及无黄斑裂孔的黄斑脱离,对照组分别有3只眼、3只眼和6只眼存在上述情况。研究组术后BCVA显著优于基线水平(P = 0.005),13只眼的BCVA有所改善,而1只眼的BCVA无变化。对照组基线和随访结束时的BCVA无显著差异(P = 0.22)。研究组BCVA的改善幅度略高于对照组(改善0.69±0.76 logMAR vs. 0.19±0.54 logMAR;P = 0.05)。两组中BCVA有任何改善的眼数无差异(13只眼[93%] vs. 11只眼[79%];P = 0.289);研究组BCVA改善超过2行的比例显著高于对照组(10只眼[71%] vs. 3只眼[21%];P = 0.009)。研究组更早实现了解剖学成功(定义为黄斑裂孔闭合和黄斑劈裂塌陷)(3.7±3.2个月vs. 6.2±3.0个月;P = 0.04)。
与单纯玻璃体切除术相比,后巩膜加固术联合玻璃体切除术可使患有黄斑劈裂的极高度近视患眼的视力有更高改善。